BackAcrivon Therapeutics Overview

Acrivon Therapeutics Total Current Liabilities

Latest total current liabilities for ACRV: $11M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$11.05M
18.42% YoYΔ $-2.50M vs prior year quarter

Peer average

Loading

Acrivon Therapeutics Total Current Liabilities History

Loading

Acrivon Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

Acrivon Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acrivon Therapeutics (ACRV) FAQ

As of the most recent data (March 2026), ACRV shows a total current liabilities of $11M. That compares with $14M in the prior-year period — down 18.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACRV's total current liabilities is now $11M (was $14M) — a 18.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acrivon Therapeutics is outperforming or lagging.

Tracking ACRV's total current liabilities over time shows whether Acrivon Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $14M in the prior-year period — down 18.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Acrivon Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $11M) with ownership activity and broader fundamentals.